OBJECTIVE: Vasa previa (VP) is a rare obstetric condition defined by the presence of fetal blood vessels overlying or close to the internal cervical os. The purpose of this study was to identify the resolution rate of vasa previa across gestation and to determine clinical and sonographic factors that are predictive of VP resolution. STUDY DESIGN: Retrospective cohort study of women diagnosed with VP in a single ultrasound unit between 2005 and 2018. VP was defined as a fetal vessel within 2 cm of the internal cervical os on transvaginal ultrasound. The primary outcome was VP resolution, defined as migration of the VP to >2cm away from the internal os. All images were re-reviewed. Chi-square, student t-test and logistic regression analysis was performed to determine variables significantly associated with VP resolution. RESULTS: 100 women with VP were included, diagnosed at a mean GA of 22.8 +/-4.9 weeks. 39 women (39.0%) had resolution of VP at a mean gestational age of 28.6 +/-4.7 weeks. Factors associated with VP resolution on univariate and regression analysis were earlier GA at diagnosis (aOR 6.10), VP not covering the internal os at diagnosis (aOR 8.29) and VP not being the result of a resolved placenta previa (aOR 2.85). The Table shows the likelihood of VP resolution in all women as well as based on the initial location of the VP. Factors not associated with VP resolution were maternal age, parity, IVF, number of fetuses, vessel type (artery, vein, or both), CL at diagnosis, velamentous cord insertion, 2-vessel umbilical cord, succenturiate lobe, uterine anomalies, and fibroids. One woman with twin pregnancy and VP resolution (at 31 weeks, 2.8cm from the internal os) presented at 33 weeks with massive bleeding and fetal demise of twin A. It was unclear if the demise was related to VP or placental abruption. CONCLUSION: 39% of vasa previas will resolve over the course of pregnancy. Earlier GA at diagnosis, VP not covering the internal os, and not having a resolved placenta previa are all independently associated with an increased likelihood of VP resolution. Women with VP should be followed serially to assess for VP resolution, as many will resolve in the third trimester. 
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1052 Brain composition differences in fetuses after laser surgery for twin-twin transfusion syndrome (TTTS) 
OBJECTIVE:
We describe the maturational pattern differences of various brain tissues between donor versus recipient twins treated with in utero laser surgery for TTTS using 3D MRI reconstruction. STUDY DESIGN: This was a prospective study of 20 patients with TTTS and dual survivors 4 weeks postoperatively. Fetal MRI scans were performed with a 1.5-T scanner. Multiple stacks of singleshot fast spin-echo T2-weighted slices of the fetal brain were obtained in the axial, sagittal, and coronal planes for each fetus. The images were reconstructed into 3D MRI volumes after motion correction. Total brain volume (TBV), cortical plate region (CR), developing white matter region (WMR), cerebellum, and ventricles were delineated using a semi-automated, atlas based segmentation method ( Figure  1(a) ). CR, WMR, cerebellum, and ventricular volumes were normalized by TBV for each subject. The CR and WMR were additionally normalized to the supratentorial structures only, called total parenchymal volume (TPV). Relationship between gestational age (GA), twin status (donor/recipient) and normalized tissue volumes were modeled using robust, multiple linear regression and tested for significance (defined as p<0.05). RESULTS: Eighteen of 20 twin pairs had sufficient image quality for analysis. The median gestational age (GA) at laser surgery was 19.8 (16.4-26.4) weeks, and 25.1 (22.1-30.7) weeks at MRI examination. Figure 1 (b-f) shows the comparative relationship between normalized tissue volumes and gestational age between the donor and recipient twin pairs. TBV was significantly lower in the donor twins (Figure 1b) , although TPV were not different between the twin pairs ( Figure 1c) . Recipients showed significantly lower proportions of CR and cerebellar volumes normalized to TBV compared to donors (Figure 1d,e) . Ventricular volumes normalized to TBV were significantly higher in the donor twins (Figure 1f ). No significant differences were detected in WMR volumes between the two groups. Recipients showed significantly lower proportions of CR normalized to TPV compared to donors. CONCLUSION: Although the total brain volume of the donor twin was smaller than that of the recipient twin, the proportional brain tissue volumes of the donor were preserved. Rather, it was the recipient twin that had relatively reduced proportions of cortical plate region and cerebellar volumes. OBJECTIVE: Abnormalities of placental cord insertion (PCI) at term has been associated with adverse obstetrical outcomes. If abnormal PCI could be reliably identified antenatally, enhanced fetal and obstetrical surveillance could potentially mitigate these associated risks. Although high resolution ultrasound (U/S) has proven useful in identifying PCI abnormalities in select obstetrical populations, the extent to which routine mid-trimester U/S screening can identify and accurately predict abnormalities of PCI at delivery is unknown.
